Ftse Mib
34.659,55
-0,29%
DAX
18.677,87
-0,45%
S&P 500
5.306,04
0,02%
NASDAQ
17.019,88
0,59%
Bitcoin
68.433,62
0,21%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oxford Immunotec Global PLC (OXFD) Oxford Immunotec Global PLC (OXFD) Notizie

OXFD

Oxford Immunotec Global (OXFD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OXFD
DataOraFonteTitoloSimboloCompagnia
14/02/202221:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OXFDOxford Immunotec Global PLC
12/03/202122:38Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OXFDOxford Immunotec Global PLC
12/03/202122:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OXFDOxford Immunotec Global PLC
08/03/202123:06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OXFDOxford Immunotec Global PLC
08/03/202115:24Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:OXFDOxford Immunotec Global PLC
04/03/202120:43PR Newswire (US)Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection...NASDAQ:OXFDOxford Immunotec Global PLC
02/03/202123:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OXFDOxford Immunotec Global PLC
26/02/202123:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OXFDOxford Immunotec Global PLC
08/02/202115:15GlobeNewswire Inc.Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to...NASDAQ:OXFDOxford Immunotec Global PLC
04/02/202115:15GlobeNewswire Inc.Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemi...NASDAQ:OXFDOxford Immunotec Global PLC
29/01/202115:58Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OXFDOxford Immunotec Global PLC
29/01/202115:28Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:OXFDOxford Immunotec Global PLC
14/01/202115:15GlobeNewswire Inc.New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19NASDAQ:OXFDOxford Immunotec Global PLC
13/01/202115:15GlobeNewswire Inc.Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vacci...NASDAQ:OXFDOxford Immunotec Global PLC
07/01/202113:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OXFDOxford Immunotec Global PLC
07/01/202113:00Business WirePerkinElmer to Acquire Oxford Immunotec Global PLCNASDAQ:OXFDOxford Immunotec Global PLC
31/12/202016:23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OXFDOxford Immunotec Global PLC
16/12/202015:15GlobeNewswire Inc.Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This WeekNASDAQ:OXFDOxford Immunotec Global PLC
10/12/202015:15GlobeNewswire Inc.Oxford Immunotec Announces the Approval of the T-Cell Select™ Reagent Kit, Used to Automate the T-SPOT®.TB Test Workflow, ...NASDAQ:OXFDOxford Immunotec Global PLC
02/12/202015:00GlobeNewswire Inc.Oxford Immunotec Signs Exclusive Distributor Agreement with RIKEN Genesis, a Subsidiary of Sysmex, to Market the T-SPOT® Dis...NASDAQ:OXFDOxford Immunotec Global PLC
23/11/202013:30GlobeNewswire Inc.Oxford Immunotec to Hold a Virtual Investor Event on December 17, 2020NASDAQ:OXFDOxford Immunotec Global PLC
10/11/202015:00GlobeNewswire Inc.Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measur...NASDAQ:OXFDOxford Immunotec Global PLC
05/11/202015:00GlobeNewswire Inc.Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell Select™ Reagent KitNASDAQ:OXFDOxford Immunotec Global PLC
03/11/202016:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OXFDOxford Immunotec Global PLC
03/11/202013:00GlobeNewswire Inc.Oxford Immunotec Reports Third Quarter 2020 Financial ResultsNASDAQ:OXFDOxford Immunotec Global PLC
22/10/202011:30GlobeNewswire Inc.UK Vaccines Taskforce has Selected Oxford Immunotec as the Sole Supplier of T cell Testing for SARS-CoV-2 Specific Responses ...NASDAQ:OXFDOxford Immunotec Global PLC
21/10/202022:05GlobeNewswire Inc.Oxford Immunotec Schedules Third Quarter 2020 Earnings Release and Conference Call for November 3, 2020NASDAQ:OXFDOxford Immunotec Global PLC
29/09/202015:00GlobeNewswire Inc.Oxford Immunotec Announces Food and Drug Administration (FDA) Clearance of the T-SPOT®.TB Test for Use in Pediatrics Over th...NASDAQ:OXFDOxford Immunotec Global PLC
22/09/202015:00GlobeNewswire Inc.Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS...NASDAQ:OXFDOxford Immunotec Global PLC
02/09/202022:08Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OXFDOxford Immunotec Global PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OXFD

La tua Cronologia

EU
H839T
H839T
EU
7761T
7761T
ASX
BD1O
Bard1 Life Sciences
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network